Most filamentous fungi, such as Aspergillus spp., are notorious for their low culturability from the infection site. It is difficult to evaluate the performance of a molecular test such as PCR when negative culture is present. Under such circumstances, it is desirable to have consecutive positive results for a molecular test. However, given the research nature of our study (not clinical care), it was not possible to obtain such samples. For this reason, we used multiple controls, including healthy volunteers, a reagent control, and negative assay controls, as well as repeated testing, to ensure the reliability of the detection. Therefore, the comments "most fungal species detected by Zhao et al. were environmental saprophytes or plant pathogens" and "positive PCR signals in blood require careful interpretation, especially if they are based on a single test" were noted and addressed in our control population. With respect to C T cutoff values, tight C T values were observed for every set of triplicates from all 6 healthy volunteers, with only one C T value (34.94) out of 18 C T values being Ͻ35. Therefore, the threshold of 35 was determined, as it correctly recognized 95% (17/18) of true-negative samples, with 5% (1/18) false positivity (␣ ϭ 0.05), which is statistically sufficient to be used as a cutoff value. Furthermore, if the 2 C T differences between the positive sample group and healthy controls resulting from this C T cutoff determination were not satisfactory, as indicated in the comment letter, a more prominent C T difference of 3 between these two groups addresses such criticism by applying a more rigid C T cutoff of 34, as suggested in our study. It should be noted that a C T value difference of 3 represents an approximate 10-fold change in target abundance.
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There also seems to have been some confusion concerning identification of mixed fungal species in three blood samples. Herein, it is necessary to reiterate the methodology used in our study. The panfungal real-time PCR targeting a highly conservative region in the 28S rRNA gene was used to screen samples positive for fungal DNA. Amplicons of this real-time PCR were ϳ80 bp and not subjected to sequencing due to the short length and the conservativeness of the target sequence. Subsequently, regular PCR assays targeting the more variable ITS1 or ITS2 region were performed on positive panfungal samples. PCR products from these amplification assays were ϳ250 to ϳ300 bp, depending on the species, and subjected to sequencing. It should be pointed out that a positive panfungal real-time PCR result does not guarantee the success of ITS PCR assays, which are more demanding of primer design because of the variance among species, as well as of DNA template intactness because of the bigger sizes of PCR amplicons, especially when the amount of fungal target DNA is near the detection limit and coexists with a large excess of human DNA. Thus, one ITS1 primer set and two redundant ITS2 primer sets were utilized simultaneously in order to increase the amplification success. When ITS1 and ITS2 sequencing results indicated different fungi with convincing identity scores, the sample was considered to be carrying mixed fungal signatures. Nevertheless, it is worth noting that ITS-based identification, especially for uncommon fungal species, has its limitation in view of the fact that the NCBI GenBank database has only a small number of such isolates (2) .
As discussed in our paper, it remains difficult to interpret these results due to the absence of blood cultures and the very limited access to detailed clinical information or diagnostic testing results. However, mold nucleic acid in blood is a rare event in the absence of some underlying disease process. The high prevalence in these patients is unusual and alarming.
